March 27, 2024
Via: Medical Device NetworkOncology is the most active area in clinical trials globally this year, as more resources than ever are being dedicated to developing and testing new cancer treatments. At the same time, there is the recurring issue of patient recruitment and […]
January 10, 2024
Via: HitConsultantEscalating competition for clinical trial sites, in tandem with other industry-wide challenges such as changing regulations; a lack of bandwidth and resources; identifying ideal sites and recruiting and retaining patients, are posing significant obstacles for sponsors and site teams within […]
October 12, 2023
Via: Medical Device NetworkUK gynaecological health start-up Daye and contract research organisation Lindus Health have teamed up to launch a clinical trial investigating a tampon capable of detecting human papillomavirus (HPV) and sexually transmitted infections (STIs). The trial, overseen by Lindus Health, will […]
June 19, 2023
Via: Medical Device NetworkChina-based medical equipment company Valgen Medtech presented the 12-month results of the DRAGONFLY-DMR trial during the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) 2023. DragonFly is a transcatheter-edge-to-edge repair (TEER) therapy that has been successfully implanted in more than 300 […]
January 24, 2023
Via: HitConsultantClinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, […]
December 27, 2022
Via: Medical Device NetworkThe healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. Along […]
September 26, 2022
Via: Medical Device NetworkArtivion has halted the PROACT Xa clinical trial, which was designed to assess if patients with an On-X mechanical aortic valve could be maintained safely and effectively on apixaban versus warfarin. The randomised, prospective trial enrolled subjects with an On-X […]
September 22, 2022
Via: Health IT AnswersTasked with reimagining patient-centric cancer clinical trials, the Bloomberg New Economy International Coalition has identified eliminating patient identification and enrollment barriers as top priorities for accelerating the development of novel cancer treatments, screening, and prevention. The priorities outlined in the […]
September 19, 2022
Via: Medical Device NetworkBoston Scientific has reported data from the PROTECTED TAVR clinical trial of the SENTINEL Cerebral Protection System. The SENTINEL device has been designed for capturing and removing the embolic debris stemming from transcatheter aortic valve replacement (TAVR) before it reaches […]
August 29, 2022
Via: medicaldevice-network.comMedtronic has announced that its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System met safety endpoints and achieved 98.7% success rate in an international clinical trial. The first-of-its-kind defibrillator has been designed for treating the dangerously fast heartbeat which may […]
July 29, 2022
Via: medicaldevice-network.comInternet of Things (IoT) is the catchall term covering devices that collect and exchange data with other devices over the internet. And, according to experts involved in their rollout in clinical trials, the sector is at a tipping point. In […]
April 27, 2022
Via: HitConsultantPrior to COVID, major technological transformation initiatives were already underway at many clinical trial sites, sponsors, and contract research organizations (CROs.) But the move to decentralized trials accelerated dramatically in 2020 and 2021–and it’s not slowing down. Survey data from […]
February 21, 2022
Via: HitConsultantThe clinical trial industry is, once again, at an uncertain crossroads. And while it might be assumed that the outsized impact of the COVID-19 pandemic has resulted in the inability to recruit patients for trials, it is instead, a challenge […]
July 1, 2021
Via: The Medical NewsA blood test to help guide the treatment of esophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway. The trial is thanks to a federal government grant of almost $2 million […]
May 6, 2021
Via: The Medical NewsThe coronavirus disease 2019 (COVID-19) pandemic has been associated with hundreds of millions of hospitalizations and over 3.2 million deaths since it first emerged in late-2019. While the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) results mostly in asymptomatic or […]
Biomarker, Innovation, Research
April 13, 2021
Via: The Medical NewsNew data published by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that an oral drug currently used in the clinical setting to […]
March 23, 2021
Via: CNBCPfizer said Tuesday it has begun an early stage clinical trial of an experimental oral antiviral drug for Covid-19. The New York-based company said the phase one trial of the drug – called PF-07321332 – is being conducted in the […]
Biomarker, Innovation, Research
December 9, 2020
Via: The Medical NewsAfter a median follow-up of 5.1 years, among women with lymph node-positive early-stage breast cancer and a recurrence score of 25 or lower who received adjuvant endocrine therapy with or without chemotherapy, postmenopausal patients had no added benefit from chemotherapy, […]
October 5, 2020
Via: The Medical NewsResults of a first-of-its-kind clinical trial shed light on when antibiotics instead of surgery might be the better choice for treating appendicitis in some patients, according to researchers with The University of Texas Health Science Center at Houston (UTHealth), who […]
October 1, 2020
Via: The Medical NewsThe immunotherapy drug atezolizumab improves survival over standard chemotherapy for many patients with newly diagnosed non-small cell lung cancer (NSCLC), according to a new study led by Yale Cancer Center (YCC) researchers. The findings, from a global randomized phase 3 […]